Skip To Main Content
Nyere Gibson on Muck Rack

Nyere Gibson

As seen in: Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nyere

Contact Nyere, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Immunotherapy for head and neck squamous cell carcinoma: current status and perspectives

|
By Amaury Daste, Mathieu Larroquette, Nyere Gibson, Matthieu Lasserre
| Future Medicine Verified
Papers of special note have been highlighted as: • of interest; • • of considerable interest • None Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study . 31(7), 942–950 ( ). • Phase III study evaluating anti-PD-L1 and CTLA-4 in the second or third line. 31(7), 942–950 (). • Phase III study evaluating anti-PD-L1 and CTLA-4 in the second or third line.
Open in Who Shared Issue with article?
See all 1 articles